NIFTY 500 › Information Technology
Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance
Filings
54 filings of IKS since February 2025; the newest 40 below.
acquisition 17, presentation 12, board outcome 11, transcript 10, results 2, credit rating 2
| Filed | Type | Subject | |
|---|---|---|---|
| 12 Nov 2026 | transcript Acquisition, Guidance, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Transcript of the Q2 FY 2026-27 Earnings Conference Call.AI summaryIKS Health filed the transcript of its Q2 FY2026-27 earnings conference call, held on November 6, 2026, covering results for the quarter and half year ended September 30, 2026. Founder and Global CEO Sachin Gupta said the company continued strong momentum in fiscal Q2, with the TruBridge integration well underway and ahead of initial expectations on EHR stickiness, patient record access and margin synergies. Management said the combined company reported revenue of about INR 1,592 crore and EBITDA of about INR 442 crore, a 28% EBITDA margin, in line with expectations. Management said the TruBridge EHR features for denial prediction, coding and clinical productivity are targeted to be live in the TruBridge EHR by Q1 FY2028, and that Project Endeavor is building an AI-native operating system for the rural and community market. Management reported four wins in the legacy IKS business, including a cross-sell into Augusta Health and three new logos. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Nov 2026 | acquisition Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about Acquisition of Turbo Health Holdings, LLC.AI summaryInventurus Knowledge Solutions Limited filed a Regulation 30 disclosure on the acquisition of Turbo Health Holdings, LLC, a US healthcare technology entity. The board of IKS Inc., a wholly owned material subsidiary incorporated in the USA, approved the acquisition of 100% shareholding on November 9, 2026 (US time) for a total consideration of USD 500,000, paid in cash. The acquisition was completed on November 10, 2026; no governmental or regulatory approvals are stated as required. The target is a newly incorporated entity (incorporated November 5, 2026) that acquired certain transferred client contracts in the ambulatory revenue cycle management business of Optum Insight; no turnover history is available. The filing states the acquisition is not a related party transaction and that promoters have no interest in the target. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Nov 2026 | presentation Guidance, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInventurus Knowledge Solutions Limited filed its investor presentation on Nov 5, 2026 for the quarter and half year ended September 30, 2026 (Q2 FY27). The presentation describes IKS Health as a healthcare enablement platform, with 16,318 employees and 640+ clinically trained staff as of Sept 30, 2026, and 1,900+ healthcare organizations as clients. Management states 90%+ of revenues come from repeat customers, with top 10 and top 5 clients averaging over 5 years vintage. Management outlines five strategic pillars, including operating model transformation in TruBridge RCM and Coding businesses and realizing operating and SG&A synergies, and cites a US$260bn total addressable market (CY 2023). The pages provided do not include the financial figures for the quarter. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Nov 2026 | board outcome Acquisition, Results | Inventurus Knowledge Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.AI summaryInventurus Knowledge Solutions Limited filed the outcome of its board meeting held on November 5, 2026, which approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Limited Review Report from Price Waterhouse Chartered Accountants LLP is enclosed; the auditor reported no material misstatement in either statement. The consolidated results include TruBridge Inc. and its subsidiaries; one step-down subsidiary was acquired on July 9, 2026 and contributed revenue from operations of Rs. 7,442.11 million and profit after tax of Rs. 1,006.38 million for the period from July 9, 2026 to September 30, 2026. The board meeting commenced at 07:35 P.M. IST and concluded at 08:36 P.M. IST. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Aug 2026 | transcript Acquisition, Guidance, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about TranscriptAI summaryFiled transcript of IKS Health's Q1 FY27 earnings conference call held on August 6, 2026, for the quarter ended June 30, 2026, uploaded to the company website. Founder and CEO Sachin Gupta said the TruBridge acquisition, which closed on July 10, 2026, adds a rural and community health system market with 2,100-plus hospitals, with the combined business expected to be just short of about $700 million in revenue. Management said the plan is to return EBITDA margins from a pro forma 26%-27% range after TruBridge consolidation to early-to-mid 30% levels, targeted under the True North goal for FY30. Management outlined five strategic pillars, including building an integrated system of action and system of record for rural and community providers and training proprietary small language models on a patient dataset of 5 million-plus patients. Management described the outsourced healthcare TAM as about $35 billion within a market of north of $260 billion, with the outsourced TAM growing about 12%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | presentation Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInventurus Knowledge Solutions filed its investor presentation on the financial results for the quarter ended June 30, 2026 (Q1 FY27), under Regulation 30 of the SEBI LODR. The presentation covers the IKS Health platform, its five strategic pillars (including AI/SLM-led workflows, cross-selling, and operating model transformation and synergies in TruBridge RCM and Coding businesses), and awards received in 2026. Headcount as of June 30, 2026 was 12,889 employees, including 1,902 clinically trained staff; the company cites 85%+ revenue from repeat customers. The pages provided do not include the financial figures for the quarter (revenue, profit or guidance numbers). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Aug 2026 | board outcome Management change, Results | Inventurus Knowledge Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryInventurus Knowledge Solutions (IKS) filed the outcome of its August 5, 2026 board meeting, which approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a limited review report from Price Waterhouse Chartered Accountants LLP. The board noted that Non-Executive Chairman and Non-Independent Director Berjis Desai (DIN 00153675) expressed unwillingness to seek re-appointment and will cease as director and chairman at the conclusion of the 20th AGM. The board designated Independent Director Clarence Carleton King II (DIN 08171208) as Non-Executive Chairman and Independent Director, effective from the conclusion of the 20th AGM. The board meeting commenced at 7:15 PM IST and concluded at 8:44 PM IST. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Aug 2026 | acquisition Acquisition, Legal | Inventurus Knowledge Solutions Limited has informed the Exchange about update on acquisition.AI summaryInventurus Knowledge Solutions Limited disclosed under Regulation 30 that it executed a syndication agreement dated August 3, 2026 relating to financing facilities for its wholly-owned subsidiary Inventurus Knowledge Solutions Inc. (IKS Inc.), the borrower. The syndication agreement lists Citigroup Global Markets Asia Limited, Deutsche Bank AG Singapore Branch, JP Morgan Chase Bank N.A. Hong Kong Branch and Export-Import Bank of India London Branch as arrangers, and Axis Trustee Services Ltd GIFT City Branch as agent. The filing says the facilities are for IKS Inc.'s acquisition of TruBridge, Inc., referred to as the Proposed Acquisition in earlier intimations dated April 23, July 2 and July 3, 2026. New lenders named include Axis Bank, DBS Bank, HDFC Bank, ICICI Bank, State Bank of India and Sumitomo Mitsui Banking Corporation, among others. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jul 2026 | acquisition Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about incorporation of step-down wholly owned subsidiary.AI summaryInventurus Knowledge Solutions Limited disclosed under Regulation 30 of SEBI LODR that its wholly owned subsidiary Inventurus Knowledge Solutions Inc has incorporated a step-down wholly owned subsidiary, Value Partners Collective ACO, LLC (VPCA), on May 5, 2026, in the USA. VPCA has been incorporated to apply for selection to participate in the Centers for Medicare & Medicaid Services' Long-term Enhanced ACO Design (LEAD) program, a voluntary 10-year model. VPCA has not been funded or capitalised; amount invested is $0, and it has nil turnover and no financial details yet. The company stated that the incorporation is not a related party transaction and that promoter/promoter group has no interest in the entity. If CMS does not select VPCA, the entity will be dissolved. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 14 Jul 2026 | acquisition Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about update on additional investment in IKS WWMG MSO LLC.AI summaryInventurus Knowledge Solutions Limited filed an update under Regulation 30 of the SEBI Listing Regulations on an additional investment in IKS WWMG MSO LLC. IKS Inc, a wholly owned subsidiary, completed the first tranche of investment of USD 2,840,000 by subscribing to 2,840,000 Common Units of WWMG MSO. Following the first tranche, IKS Inc's holding in WWMG MSO increased from 48.02% to 51.88% of outstanding equity interests. The filing refers to an earlier board approval disclosed on June 29, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Jul 2026 | acquisition Acquisition, Legal | Inventurus Knowledge Solutions Limited has informed the Exchange about update on Acquisition.AI summaryInventurus Knowledge Solutions Limited filed a Regulation 30 disclosure on the subordination agreement executed on July 10, 2026, related to its proposed acquisition of TruBridge, Inc. through wholly-owned subsidiary IKS Inc. The subordination agreement covers intercompany debts and liabilities owed to IKS Inc., the Company, Aquity Holdings, Inc., Aquity Solutions, LLC and Aquity Solutions India Private Limited, with Axis Trustee Services Ltd. GIFT City Branch as a party. Intercompany debt will rank and remain subordinated to IKS Inc.'s obligations under financing facilities aggregating up to USD 635,000,000 from certain lenders. The filing follows earlier intimations dated April 23, July 2, July 3, July 6 and July 9, 2026 on the acquisition and financing. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 09 Jul 2026 | acquisition Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about completion of Acquisition of TruBridge.AI summaryInventurus Knowledge Solutions Limited disclosed under Regulation 30 that its wholly-owned US subsidiary IKS Inc. has completed the acquisition of 100% of TruBridge, Inc. Total consideration for the acquisition is USD 557 Million. The acquisition was effected through the merger of IKS Next Horizon, Inc. with TruBridge under the agreement and plan of merger dated April 23, 2026, in line with Delaware law. The company had earlier intimated Board approval for the proposed acquisition on April 23, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Jul 2026 | acquisition Acquisition, Capex, Legal | Inventurus Knowledge Solutions Limited has informed the Exchange about update on Acquisition.AI summaryInventurus Knowledge Solutions Limited disclosed under Regulation 30 that it issued a corporate guarantee for a maximum aggregate amount of USD 603,750,000 in favour of lenders including Citibank N.A., Deutsche Bank AG Singapore Branch, JPMorgan Chase Bank and Export-Import Bank of India, London Branch. The guarantee covers facilities of up to USD 575,000,000 to be availed by its wholly-owned subsidiary IKS Inc. in connection with the proposed acquisition of TruBridge, Inc. IKS Inc. refinanced an existing term loan of USD 70,000,000 using the proceeds of these facilities. The existing corporate guarantee of USD 77,000,000 issued by the company for that term loan has been released. The guarantee will be treated as a contingent liability in the company's financial statements. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Jul 2026 | acquisition Acquisition, Legal | Inventurus Knowledge Solutions Limited has informed the Exchange about update on Acquisition.AI summaryInventurus Knowledge Solutions Limited disclosed under Regulation 30 that, in connection with the proposed acquisition of TruBridge, Inc. by its wholly-owned subsidiary IKS Inc., several agreements were executed on July 3, 2026. The executed documents are a facilities agreement with Axis Trustee Services Ltd. (GIFT City Branch) as agent and security agent, a pledge and security agreement, a power of attorney in favour of the security agent, and a letter of comfort issued by the company to the agent. The facilities agreement is with IKS Inc. as borrower, with Citibank, Deutsche Bank, Export-Import Bank of India and JPMorgan Chase as original lenders, to finance the acquisition. The letter of comfort confirms the company will continue to exercise effective oversight of IKS Inc.'s governance, capital management and investment strategies. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 Jul 2026 | acquisition Acquisition, Legal | Inventurus Knowledge Solutions Limited has informed the Exchange about update on Acquisition.AI summaryInventurus Knowledge Solutions Limited filed a Regulation 30 disclosure updating its April 23, 2026 approvals for the acquisition of TruBridge, Inc. by its wholly-owned subsidiary IKS Inc. The aggregate amount of facilities to be availed by IKS Inc. has been reduced from up to USD 670,000,000 to up to USD 635,000,000. The Board approved adding Healthcare Resource Group, Inc. (HRG Inc.) to the security package, including security over its assets, a pledge over its shares, and a guarantee by HRG Inc., effective on consummation of the acquisition. Certain security and non-disposal undertakings are subject to shareholder approval by special resolution. The Board meeting was held on July 2, 2026, from 6:05 p.m. to 6:26 p.m. (IST). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Jun 2026 | acquisition Acquisition, Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about additional investment in IKS WWMG MSO LLC, an associate company of Inventurus Knowledge Solutions Inc ( IKS Inc ), a wholly owned subsidiary of the Company.AI summaryBoard of Inventurus Knowledge Solutions Limited approved, at its meeting on June 29, 2026, an additional investment of up to USD 15,000,000 by its wholly owned subsidiary IKS Inc in IKS WWMG MSO LLC, an associate company, by subscribing to up to 15,000,000 common units at USD 1 per unit. The investment, payable in cash and in one or more tranches by March 31, 2029, would raise IKS Inc's shareholding in WWMG MSO from 48.02% to 63.49%. The first tranche of up to USD 3,000,000 is to be invested on or before July 3, 2026. WWMG MSO was incorporated on June 12, 2025 in the USA to provide management and support services to physician practices; it reported nil revenue and other income of USD 0.08 million for FY 2025-26, with net worth of USD 16.02 million. Management said the investment is strategic, aimed at moving from service provider to transformation partner and strengthening the care enablement platform. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Jun 2026 | credit rating Rating | Inventurus Knowledge Solutions Limited has informed the Exchange about Credit Rating- New - Submission of Press Release issued by CARE Ratings Limited in relation to Rating assigned to the Company.AI summaryFiling submits CARE Ratings press release dated June 22, 2026 on the credit rating assigned to Inventurus Knowledge Solutions Limited (IKS Health). Issuer rating assigned at CARE A+; Stable, with outlook Stable. Rating drivers include the proposed debt-funded acquisition of TruBridge Inc. for about $560 million (about ₹5,320 crore), expected to complete in Q2FY27 subject to US regulatory and shareholder approvals. CARE notes FY26 consolidated total operating income of about ₹3,194 crore (up about 20% y-o-y), net debt/PBILDT of 0.35x and overall gearing of 0.27x as on March 31, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 19 Jun 2026 | credit rating Rating | Inventurus Knowledge Solutions Limited has informed the Exchange about Credit Rating- NewAI summaryCARE Ratings Limited assigned an issuer rating of CARE A+; Stable to the Company, per its letter dated June 19, 2026. The rating is an opinion on the Company's general creditworthiness and is not specific to any debt instrument. The filing was made under Regulation 30 of the SEBI (LODR) Regulations, 2015 to BSE and NSE. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 20 May 2026 | transcript Acquisition, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about TranscriptAI summaryIKS (Inventurus Knowledge Solutions) filed the transcript of its Q4 FY26 earnings conference call held on May 14, 2026, covering results for the quarter and year ended March 31, 2026, uploaded to the company website. Management (Founder and Global CEO Sachin Gupta) said IKS has about 600-plus provider clients, down from 700-plus a year earlier and about 900 at the time of the AQuity acquisition, as it cut the tail of small clients; it expects to settle between 500 and 600. Gupta said 90% of revenues come from repeat customers and that headcount was 13,331 as of March 31, 2026, including 1,981 clinically trained staff, up from 12,661 a year earlier. Gupta said the outsourced US healthcare TAM is about $35 billion, growing about 12%, and that the company is pivoting its go-to-market for large health systems to a land-and-expand, point-solution approach. Gupta referred to a pending acquisition of TruBridge, announced a few weeks earlier, which he said would add a sixth strategic pillar if closed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 14 May 2026 | acquisition Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about update under Regulation 30(7) of the SEBI LODR Regulations with respect to Acquisition of Arai Solutions Private Limited.AI summaryUpdate under Regulation 30(7) of SEBI LODR Regulations on the acquisition of Arai Solutions Private Limited, referring to a disclosure made on May 13, 2026. The Company has acquired 10,000 equity shares of INR 10 each of Arai Solutions Private Limited. Consideration for the acquisition is INR 11,00,00,000 (INR 110 crore). The company states that the event disclosed on May 13, 2026 has now been completed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | acquisition Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about AcquisitionAI summaryInventurus Knowledge Solutions Limited's board approved on May 13, 2026 the acquisition of 100% of the share capital of Arai Solutions Private Limited for a total cash consideration of INR 11,00,00,000 (INR 11 crore). The target, incorporated on April 5, 2024, provides AI consultancy services, including in healthcare; its FY 2025-26 revenue from operations was INR 5,462,600, total income INR 5,538,394 and net worth INR 956,433. The acquisition is not a related party transaction, no governmental or regulatory approvals are required, and completion is expected by or before June 20, 2026. On completion, the target will become a wholly owned subsidiary; the company says the deal enhances its AI capabilities and accelerates its AI R&D. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | presentation Acquisition, Capex, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInventurus Knowledge Solutions (IKS) filed its Q4 FY26 investor presentation on financial results for the quarter and year ended March 31, 2026. The presentation describes IKS Health as an AI-native healthcare enablement platform serving 600+ healthcare organizations (700+ in Q4 FY25), with 13,331 employees and clinically trained staff as of March 31, 2026. It reports 90%+ of revenues from repeat customers and a top-10 / top-5 client average vintage of 5+ years. Management highlights integration of the AQuity acquisition, margin expansion, and launches including agentic workflows for clinical documentation, coding and prior authorization, and the MyCareHub patient engagement platform. Management also cites the acquihire of ThinkDTM and a partnership with Certilytics, and states it earned US$3 million NEVA in Palomar in its first year. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | board outcome Acquisition, Management change, Results | Inventurus Knowledge Solutions Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryBoard of Inventurus Knowledge Solutions Limited approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with unmodified audit opinions from Price Waterhouse Chartered Accountants LLP. Board approved acquisition of 100% share capital of Arai Solutions Private Limited for a total cash consideration of INR 11,00,00,000 (INR 11 crore); the target will become a wholly-owned subsidiary on completion. Board approved change in senior management personnel effective May 14, 2026 (details in Annexure C; the filing text provided does not name the person). Board approved re-appointment of M/s KKC & Associates LLP as Internal Auditor for the internal audit period covering FY 2026-27. Board meeting commenced at 05:15 PM IST and concluded at 06:39 PM IST on May 13, 2026. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 29 Apr 2026 | transcript Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about Transcript.AI summaryInventurus Knowledge Solutions (IKS) filed the transcript of its conference call held on April 24, 2026, on the announced agreement to acquire TruBridge, and said it is also available on the company website. Founder and Global CEO Sachin Gupta said IKS signed a definitive merger agreement with TruBridge on April 23, 2026, describing it as a strategic acquisition to combine IKS's platform system of action with TruBridge's system of record. Gupta said TruBridge is a leader in the rural hospital segment, citing about 2,200 US rural hospitals driving $164 billion of revenue, with TruBridge holding about 700 hospitals in the 0-50 bed segment. Gupta said TruBridge's RCM business is about a $220 million business run with roughly 3,500 FTEs globally, and that the combination is intended to build a proprietary AI training corpus and reduce human involvement. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 24 Apr 2026 | presentation Acquisition, Capex, Guidance, Legal | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryIKS Health (Inventurus Knowledge Solutions) filed investor FAQs on its announced agreement to acquire TruBridge, a US healthcare EHR and RCM company, funded entirely through debt. Management cites a $575 million+ whitespace for cross-selling IKS's Care Enablement Platform into TruBridge's EHR client base, and expects closing in Q2 FY2027 subject to shareholder and regulatory approvals. Post-transaction leverage is expected at about 3 times, and synergies are expected over 3 years with a target of about INR 3000 crore EBITDA for the combined entity by FY30. Management expects the transaction to be EPS accretive in Year 1 and said it is subject to a US antitrust review by the FTC or DOJ. Management addressed TruBridge's delayed Q4 results due to immaterial out-of-period accounting adjustments, stating the final audit report was unqualified and that there is no current class action lawsuit. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | presentation Acquisition, Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInventurus Knowledge Solutions (IKS Health) filed a conference call presentation titled "IKS Health Announces Agreement to Acquire TruBridge", dated April 23, 2026, under Regulation 30 of the SEBI Listing Regulations. The presentation covers the strategic rationale for the acquisition of TruBridge, Inc., a transaction overview, market overview and TruBridge positioning, and value creation. Management frames the combined offering as a "system of record plus system of action" healthcare operating system, linking EHR data with agentic AI care-enablement workflows. Management states that monetization is expected to shift from users or seats to outcomes delivered, and that the closed-loop model creates a long-term structural advantage. The pages provided do not include deal size, consideration or closing timeline. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | presentation Acquisition, Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryConference call presentation titled "IKS Health Announces Agreement to Acquire TruBridge" filed under Regulation 30, dated April 23, 2026. The presentation covers the strategic rationale for the acquisition of TruBridge, Inc., with sections on transaction overview, market overview and TruBridge positioning, and value creation. It describes a shift from point-solution and system-of-record electronic health records to a combined "system of record + system of action" healthcare operating system, with AI-enabled workflows. Management states that monetization is expected to shift from users or seats to outcomes delivered, and that the value layer is the system that owns data, workflows and execution. The pages reviewed do not include the transaction size, consideration or closing timeline. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 23 Apr 2026 | acquisition Acquisition, Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about Acquisition of TruBridge Inc.AI summaryInventurus Knowledge Solutions Inc. (IKS Inc.), a wholly owned material subsidiary, agreed on April 23, 2026 to acquire 100% of TruBridge Inc., a US healthcare IT and revenue cycle management provider, for a total consideration of up to USD 565,000,000, subject to customary adjustments for net debts and selling expenses. The acquisition will be done by merging IKS Next Horizon, Inc. with TruBridge under Delaware law, subject to customary closing conditions including shareholder and regulatory approvals; TruBridge is to become a material indirect subsidiary. TruBridge's CY 2025 sales revenue was USD 346,836 thousand; the acquisition is to be funded by facilities of up to USD 670,000,000 from Citibank N.A., Deutsche Bank AG Singapore Branch and JPMorgan Chase Bank, N.A., Hong Kong Branch, secured by pledges, security interests and corporate guarantees. Management stated the acquisition diversifies the business into SaaS EHR and helps offer an integrated EMR and care enablement platform. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 02 Apr 2026 | acquisition Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about update with respect to investment in Inventurus Knowledge Solutions, Inc., a wholly owned subsidiary.AI summaryInventurus Knowledge Solutions Limited filed an update under Regulation 30(7) of SEBI LODR on its investment in Inventurus Knowledge Solutions, Inc., its wholly owned subsidiary. The company acquired 32,635 shares of IKS Inc. as the second tranche of investment, amounting to USD 20,990,505. The filing states that the event disclosed on March 13, 2026 (Board approval of further investment in IKS Inc.) is now completed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 27 Mar 2026 | acquisition Acquisition | Inventurus Knowledge Solutions Limited has informed the Exchange about Update with respect to investment in Inventurus Knowledge Solutions, Inc., a wholly owned subsidiary.AI summaryInventurus Knowledge Solutions Limited filed an update under Regulation 30(7) of SEBI LODR Regulations, following its March 13, 2026 disclosure on Board approval of further investment in its wholly owned subsidiary Inventurus Knowledge Solutions, Inc. (IKS Inc.). The Company has acquired 29,541 shares of IKS Inc. as the first tranche of the investment. The first tranche amounts to USD 19,000,476. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 Mar 2026 | acquisition Acquisition, Capex | Inventurus Knowledge Solutions Limited has informed the Exchange about further investment in Inventurus Knowledge Solutions, Inc., a wholly owned subsidiary.AI summaryInventurus Knowledge Solutions Limited's board approved on March 13, 2026 a further investment of up to USD 40 Mn in its wholly owned subsidiary Inventurus Knowledge Solutions, Inc. (IKS Inc.). The investment is cash consideration, payable in two tranches; the first tranche is USD 20 Mn at USD 643.19 per share for up to 31,096 equity shares, and the balance 50% will be made in due course. The filing states the Company's shareholding in IKS Inc. remains the same, and completion is expected on or before May 31, 2026. IKS Inc. reported revenue from operations of INR 6,941.11 Mn in FY 2024-25 (FY 2023-24: INR 7,027.85 Mn; FY 2022-23: INR 6,054.66 Mn). Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Feb 2026 | transcript Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Transcript of the Q3 FY 2025-26 Earnings Conference Call.AI summaryInventurus Knowledge Solutions (IKS Health) filed the transcript of its Q3 FY2025-26 earnings conference call held on February 5, 2026, covering the quarter and nine months ended December 31, 2025. Management (Founder and CEO Sachin Gupta) said revenue grew 24% year-on-year in rupee terms (19% in dollar terms) while headcount grew about 1.5% to roughly 13,350. Management said the AQuity integration is in its final stages, with margins reached faster than originally expected, and that cross-sell into AQuity's health systems is starting to show traction. Management said KLAS ratings now place the company best in class in clinical documentation and revenue cycle management. Management described a new net economic value add advance model, citing a first deal with Palomar Health in which $16.5 million of net economic value add benefits were advanced. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 04 Feb 2026 | presentation Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInventurus Knowledge Solutions filed its investor presentation on results for the quarter and nine months ended December 31, 2025 (Q3 FY26). Q3 revenue from operations was INR 8,150 million, up 24% YoY in INR (19% YoY in USD). Q3 EBITDA margin was 35% and PAT margin 22%; EBITDA grew 40% YoY and PAT grew 41% YoY. Management said revenue from top 10 customers was INR 3,943 million (48% of revenue), with 90+% of revenues from repeat customers and 450+ enterprise customers. Management highlighted the first-year NEVA of $3 million earned in Palomar despite staggered implementation, and a 2026 Best in KLAS award for Virtual Scribing Services. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 04 Feb 2026 | board outcome Results | Inventurus Knowledge Solutions Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryInventurus Knowledge Solutions Limited filed the outcome of its board meeting held February 4, 2026, which approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Financial Results and the Limited Review Reports issued by Price Waterhouse Chartered Accountants LLP are enclosed with the filing. The board meeting commenced at 06:45 P.M. IST and concluded at 07:43 P.M. IST. The auditor's review reports state that one subsidiary reported total revenues of Rs. 572.46 million for the quarter ended December 31, 2025 and Rs. 1,718.48 million for the nine-month period, and the auditor's conclusion is not modified. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Nov 2025 | transcript Guidance, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Transcript of the Q2HY FY 2025-26 Earnings Conference Call.AI summaryIKS (Inventurus Knowledge Solutions) filed the transcript of its Q2 FY2025-26 earnings conference call held on October 31, 2025, for the quarter and half year ended September 30, 2025. Management reported Q2 FY26 revenue of INR 781 crores, up 22% year-on-year and 5.5% quarter-on-quarter; EBITDA of about INR 272 crores (up 43% year-on-year) and PAT of about INR 181 crores (up 60% year-on-year), as stated by the CEO Sachin Gupta. Management said the company's TAM is growing at about 12% and that growth above that rate means market share gains; the CEO said revenue growth was 17% in US dollar terms on a constant currency basis. The CEO said the company expects EBITDA margins in the early to mid 30s and that it reached this level about three or four quarters earlier than planned. Management said top 10 customers now make up 45% of revenue, with average tenure of about six years, and that repeat customers account for 85%-plus of revenue. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2025 | presentation Capex, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation and FAQs filed under Regulation 30 on the financial results for the quarter and half year ended September 30, 2025 (Q2 FY26). The presentation describes IKS Health as a healthcare enablement platform serving 640+ healthcare organizations (Q2 26), with 12,940 employees/clinically trained staff as of September 30, 2025. Management highlights include launch of an AI-native agentic platform, Scribble Now, autonomous coding for two medical specialities, and an Epic integration, with 85+% of revenues from repeat customers. The presentation cites a US$260bn total addressable market and 8% TAM CAGR (2023-2028E), per Zinnov. The pages provided do not include the reported revenue, profit or other financial figures. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2025 | board outcome Results | Inventurus Knowledge Solutions Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2025.AI summaryInventurus Knowledge Solutions Limited filed the outcome of its board meeting held on October 30, 2025 (meeting ran 7:00 PM to 7:55 PM IST). The board approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The results and the limited review reports from Price Waterhouse Chartered Accountants LLP are enclosed as Annexure A. The auditor's review reports state no modification of conclusion; one subsidiary's interim information was reviewed by other auditors, and one subsidiary and one associate were not reviewed by their auditors and were stated by management to be not material to the group. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 30 Oct 2025 | board outcome Results | Inventurus Knowledge Solutions Limited has informed the Exchange regarding Outcome of the Board Meeting held on October 30, 2025 Unaudited standalone and consolidated financial results of the Company for the quarter and half year ended SeptAI summaryInventurus Knowledge Solutions Limited filed the outcome of its board meeting held on October 30, 2025, under Regulation 30 of SEBI LODR Regulations. The board approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The Limited Review Reports from statutory auditor Price Waterhouse Chartered Accountants LLP are enclosed as Annexure A, with an unmodified conclusion. The board meeting commenced at 7:00 P.M. IST and concluded at 7:55 P.M. IST. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Aug 2025 | transcript Guidance, Management change, Results | Inventurus Knowledge Solutions Limited has informed the Exchange about TranscriptAI summaryFiled the transcript of IKS Health's Q1 FY26 earnings conference call, held on August 1, 2025, for the quarter ended June 30, 2025, uploaded to the company website. Founder and Global CEO Sachin Gupta said the quarter was a solid performance and that he is moving from whole-time director to group global CEO, with Nithya Balasubramanian made whole-time director, a technical change tied to his US residence. Management said 95% of revenue is repeat revenue, customer count fell from about 800 at October 2023 to about 650, and global headcount was 12,368 FTEs versus 13,277 a year earlier. Management said the outsourced TAM of $34-35 billion is growing about 12% versus 8% for the overall market, and that AQuity margin expansion is about two-thirds done. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 31 Jul 2025 | presentation Results | Inventurus Knowledge Solutions Limited has informed the Exchange about Investor PresentationAI summaryInventurus Knowledge Solutions filed its investor presentation on Q1 FY26 results (quarter ended June 30, 2025). Revenue from operations was INR 7,401 mn, up 16% YoY in INR (13% YoY in USD). EBITDA margin was 32% and PAT margin 20%; EBITDA grew 36% YoY and PAT grew 59% YoY. The company reported 12,368 total employees, 450+ enterprise-level customers, and revenue from top 10 customers of INR 3,213 mn (43%). Key client wins cited include expanded partnerships with OrthoNY and a top 5 US health system, and new partnerships with Mission Community Hospital and Bicycle Health. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.